CROI 2024 Program Guide

Poster Sessions by Category

E. Neuropathogenesis and Neurologic Complications of HIV and SARS CoV-2 Infection and Neurologic Complications of HIV in Adults P-E6 Cerebrospinal Fluid, Blood Biomarkers, and Neurodegeneration in NeuroHIV (Tuesday) P-E7 Neuroimaging in HIV (Wednesday) P-E8 Omics Studies in NeuroHIV (Wednesday) P-E9 Aging and NeuroHIV (Wednesday) F. Clinical Pharmacology in Adults P-F1 Understanding Drug-Drug Interactions and Sanctuary Site Pharmacology (Monday) P-F2 Important Antiretroviral Adherence and Pharmacokinetic Measures (Tuesday) P-F3 Long-Acting Injectables, Broadly Neutralizing Antibodies, and New Drugs, Oh My! (Wednesday) G. Antiviral Therapy: Pre-Clinical Data, Randomized Trials, Efficacy, and Effectiveness Studies in HIV or SARS-CoV-2 or Mpox Virus in Adults P-G1 Treatment With Currently Available Long-Acting Antiretroviral Therapy (Monday) P-G2 Novel Antiretrovirals Development: More Than You Think! (Wednesday) P-G3 Should I Stay or Should I Go: Switching Oral Antiretroviral Therapy (Tuesday) P-G4 Rollout of Integrase Strand Transfer Inhibitors in Low- and Middle- Income Countries (Monday) P-G5 New Formulations of Current Integrase Strand Transfer Inhibitors: Length Matters (Wednesday) P-G6 Treatment and Prevention of SARS-CoV-2 Infection (Tuesday) H. Resistance of HIV or SARS-CoV-2 to Small Molecules and Antibodies in Adults P-H1 Dolutegravir Treatment and Resistance in Resource-Limited Settings (Wednesday) P-H2 Resistance to Specific Drugs: Lenacapavir, Tecovirimat, and Dolutegravir (Monday) P-H3 Broadly Neutralizing Antibodies and Resistance (Tuesday) P-H4 Archived Mutations and Sustained Suppression (Wednesday) I. Hepatitis Viruses and Liver Complications in Adults P-I1 Elimination of Hepatitis C (Monday) P-I2 Life After HCV Sustained Virologic Response (Monday) P-I3 HBV and HDV: Epidemiology, Natural History, and Pathogenesis (Tuesday) P-I4 HBV and HDV Treatment and Cure (Tuesday) P-I5 HIV and Steatotic Liver Disease (Wednesday) J. HIV-Related Malignancies and Tumor Viruses P-J1 Cancer Pathogenesis and Natural History: Kaposi Sarcoma and General (Monday) P-J2 HIV-Associated Malignancies: Epidemiology, Incidence, and Demographics (Wednesday) P-J3 Anal and Cervical Cancer: Pathogenesis, Screening, and Treatment (Tuesday) P-J4 Other Cancers Complicating HIV Infection (Monday) K. Cardiovascular Complications of HIV Infection and Antiretroviral Therapy P-K1 Cardiovascular Disease Biomarkers (Monday)

Poster Sessions by Category

CROI 2024 181